ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3,1,Headache,Headaches NEC,Headaches,Nerv,N
4,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
6,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6,3,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
6,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
8,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
8,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
10,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
12,1,Headache,Headaches NEC,Headaches,Nerv,N
12,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,1,Poikiloderma,Skin and subcutaneous malformations and anomalies NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
14,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
16,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
16,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
18,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
19,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
20,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Bronchospasm paradoxical,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
22,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
23,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
23,3,Headache,Headaches NEC,Headaches,Nerv,N
24,1,Headache,Headaches NEC,Headaches,Nerv,N
25,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
26,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
27,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
27,2,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
28,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
29,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
29,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
30,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
33,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
34,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
34,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
35,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
35,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
36,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
36,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
37,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
38,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
39,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
40,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
41,1,Essential tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
42,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
43,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
43,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
44,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
44,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
45,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
46,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
46,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
46,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
46,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
47,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
47,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
48,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
48,2,Headache,Headaches NEC,Headaches,Nerv,N
49,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
49,2,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
49,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
49,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
49,5,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
49,6,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
49,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
50,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
51,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,1,Migraine,Migraine headaches,Headaches,Nerv,N
52,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
53,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
53,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
53,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
53,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
54,1,Headache,Headaches NEC,Headaches,Nerv,N
55,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
58,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
58,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
59,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
59,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
59,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
59,4,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
59,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
59,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
59,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
59,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
59,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
59,10,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
59,11,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
59,12,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
59,13,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
60,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
61,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
62,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
66,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
